Schedule 13D ownership disclosure

KARUNA THERAPEUTICS INC

Security class unavailable · CUSIP: 48576A100

Event date: 2019-07-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,729,352
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-033738
Form type
SC 13D
Filer
Karuna Therapeutics, Inc.
CIK
CIK 1771917
Filed
Jul 03, 2019
Reporting period
Jul 02, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub